CVS · CVS HEALTH Corp · Proposed Sales
$86.46
+1.26 (+1.48%)
At close · Oct 2
Return incl. dividend (before tax)
Market Cap
$110.82B
Shares
1.28B
Volume · Oct 2
10.46M
Avg daily vol (3M)
7.72M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-05-22 | AGUIRRE FERNANDO | Director | 2,263 | 2026-05-20 | TD Securities (USA) LLC |
| 2026-05-21 | FARAH ROGER N | Director | 2,817 | 2026-05-21 | Charles Schwab Corp. |
| 2026-05-08 | TILAK MANDADI | Officer | 69,551 | 2026-05-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-08-19 | Finucane Anne A. | Director | 7,500 | 2025-08-20 | Merrill Lynch, Pierce, Fenner & Smith Incorporated |
| 2025-03-05 | Clark James David | Officer | 7,513 | 2025-03-05 | MORGAN STANLEY SMITH BARNEY LLC, EXECUTIVE SERVICES |
| 2024-02-16 | PREM S SHAH | Officer | 29,473 | 2024-02-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2023-08-03 | Clark James David | Officer | 25,759 | 2023-08-03 | ETRADE FINANCIAL CORPORATION |
Showing 1–7 of 7 filings